Caplin Point Laboratories enters into a license & distribution agreement

With Cycle Pharmaceuticals, UK

Caplin Point Laboratories announced that a license and distribution agreement has been made and entered by and between Caplin Point Laboratories, India and Cycle Pharmaceuticals, a Limited Company having its principal offices at Cambridge, UK.

Cycle Pharmaceuticals is one of the niche global pharmaceutical companies with unique products and sharp focus on key geographies like USA and Europe.

Under this agreement, Caplin Point shall be responsible for developing and manufacturing identified liquid injectable products whereas Cycle Pharmaceuticals shall be holding this ANDA and commercialize the same in USA.

This is a product specific agreement for United States of America. Currently one product is featuring in the contract.

Caplin Point has already received milestone payment for one product and the product development cum dossier preparation have just commenced.

Powered by Capital Market - Live News